サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1574996

病院内感染症検査市場：感染タイプ別、検査技術別、検査タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Hospital-Acquired Disease Testing Market, By Infection Type, By Testing Technology, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
病院内感染症検査市場：感染タイプ別、検査技術別、検査タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

病院内感染症検査市場規模は2023年に122億9,032万米ドルとなり、2024年から2032年にかけてCAGR 15.90%で拡大

病院内感染症検査市場-市場力学

病院内感染の増加が病院内感染症検査市場における高度な検査ソリューションの需要を促進

病院内感染（HAI）の増加により、ヘルスケア環境における高度な検査ソリューションの需要が大幅に増加しています。尿路感染症（UTI）、手術部位感染症、血流感染症などのこれらの感染症は、患者の健康に深刻なリスクをもたらし、入院期間の延長や死亡率の上昇につながっています。米国疾病予防管理センター（CDC）によると、HAIは毎年数百万人の患者に影響を及ぼしており、より正確で迅速な診断ツールの開発が求められています。世界各国の政府やヘルスケア機関は、HAIと闘うためのイニシアチブを開始しました。例えば、世界保健機関（WHO）は厳格な衛生プロトコルを推進し、英国のような国は感染率の高い病院に対する金銭的罰則を導入しています。ポリメラーゼ連鎖反応（PCR）や迅速診断検査など、リアルタイムで正確な検査方法への注目が高まっていることが、院内感染検査のさらなる進歩を促進すると予想されます。

病院内感染症検査市場-主要洞察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約15.90%のCAGRで毎年成長すると予測されています。

感染タイプ別では、尿路感染症が2023年に最大市場シェアを示すと予測

検査技術別では、PCR（ポリメラーゼ連鎖反応）が2023年の主要タイプでした。

検査タイプ別では、2023年に分子診断学が主要タイプとなっています。

地域別では、北米が2023年の売上高でトップ

市場セグメンテーション分析：病院内感染症検査市場：

病院内感染症検査の世界市場は、感染タイプ、検査技術、検査タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は感染タイプに基づいて4つのカテゴリーに分けられる：尿路感染症、手術部位感染症、呼吸器感染症、血流感染症です。尿路感染症（UTI）はヘルスケア環境での流行により最も高く、次いで手術部位感染症が術後の重大な懸念事項です。次いで呼吸器感染症で、血流感染症は最も一般的ではないが深刻です。

市場は検査技術によって4つのカテゴリーに分けられる：PCR（ポリメラーゼ連鎖反応）、ELISA（酵素結合免疫吸着測定法）、微生物培養、迅速診断です。PCR（ポリメラーゼ連鎖反応法）はその正確さとスピードでトップに立ち、次いでELISA（酵素結合免疫吸着測定法）が抗体検出に広く使用されています。微生物培養はその次で、迅速診断法は最も優先順位が低いです。

病院内感染症検査市場-地理的インサイト

病院内感染症検査市場は地域差が大きく、北米は先進的なヘルスケアインフラと入院患者の約31人に1人が罹患する病院内感染症（HAI）の発生率の高さからトップです。欧州は、厳格な規制と感染防止対策に対する意識の高まりが追い風となり、僅差で続いています。アジア太平洋では、急速な都市化と医療施設の拡大が市場の成長に寄与しており、特にインドや中国のような国では院内感染が喫緊の課題となっています。世界保健機関（WHO）の世界感染防止管理ネットワーク（Global Infection Prevention and Control Network）などのイニシアチブは、低資源環境におけるHAIのサーベイランスと管理を強化することを目的としており、需要をさらに刺激しています。一方、ラテンアメリカと中東では、感染率の上昇に対処するために病院が検査能力をアップグレードしており、成長を目の当たりにしています。これらの地域では、先進的な診断技術の導入が進んでおり、ヘルスケア環境における患者の安全性とケアの質の向上を目指す世界の動向を示しています。

病院内感染症検査市場-競合情勢：

病院内感染症検査市場の競合情勢は、Abbott Laboratories社、Roche Diagnostics社、bioMerieux社などの主要企業が北米をリードしているのが特徴です。続いて欧州では、シーメンス・ヘルスイニアーズやサーモフィッシャーサイエンティフィックが戦略的提携や感染症検出法の革新を通じて、その地位を強化しています。アジア太平洋地域では、インドや中国のような国々が需要の増加に対応するために検査能力を増強しており、院内感染の蔓延の増加を背景に、地元企業が台頭してきています。特にインド政府は、病院における感染管理の強化に向けたイニシアチブを打ち出しており、市場の成長をさらに後押ししています。一方、ラテンアメリカや中東では、各社が販売網の拡大とHAIに対する意識の向上に注力しており、市場力学に寄与しています。全体として、競合情勢は、多様なヘルスケア環境において患者の転帰を改善することを目的とした技術革新と戦略的提携によって特徴付けられています。

目次

第1章 病院内感染症検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 病院内感染症検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 病院内感染症検査業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 病院内感染症検査市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 病院内感染症検査市場情勢

  • 病院内感染症検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 病院内感染症検査市場- 感染タイプ別

  • 概要
    • 感染タイプ別セグメントシェア分析
    • 尿路感染症
    • 手術部位感染
    • 呼吸器感染症
    • 血流感染症

第8章 病院内感染症検査市場- 検査技術別

  • 概要
    • 検査技術別セグメントシェア分析
    • PCR（ポリメラーゼ連鎖反応）
    • ELISA（酵素免疫測定法）
    • 微生物培養
    • 迅速な診断

第9章 病院内感染症検査市場- 検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • 分子診断
    • 免疫測定
    • 従来の培養検査

第10章 病院内感染症検査市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 診断検査室
    • 外来手術センター
    • 学術調査機関

第11章 病院内感染症検査市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 病院内感染症検査業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cardinal Health, Inc.
    • Cepheid Inc.（A Danaher Company）
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • GenMark Diagnostics, Inc.
    • Hologic, Inc.
    • Luminex Corporation
    • Merck KGaA
    • Qiagen NV
    • QuidelOrtho Corporation
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3983

REPORT HIGHLIGHT

Hospital-Acquired Disease Testing Market size was valued at USD 12,290.32 Million in 2023, expanding at a CAGR of 15.90% from 2024 to 2032.

The Hospital-Acquired Disease Testing Market focuses on diagnostic tests for infections acquired in healthcare settings, impacting patient safety and hospital resources. Rising incidences of hospital-acquired infections (HAIs), such as MRSA and C. difficile, emphasize the need for effective testing solutions; for instance, HAIs affect approximately 1 in 31 hospital patients in the U.S., highlighting significant challenges for healthcare providers. Increasing awareness about infection control and advancements in molecular diagnostics are key drivers for market growth. However, factors such as high testing costs and stringent regulatory frameworks may hinder adoption. Opportunities abound in developing innovative rapid testing methods and expanding testing capabilities, particularly in emerging markets where healthcare infrastructure is improving. As hospitals prioritize patient safety and regulatory compliance, investments in advanced testing technologies are expected to rise, fostering a more proactive approach to infection management.

Hospital-Acquired Disease Testing Market- Market Dynamics

Rising Incidences of Hospital-Acquired Infections Propel Demand for Advanced Testing Solutions in the Hospital-Acquired Disease Testing Market

The rising incidence of hospital-acquired infections (HAIs) has significantly increased the demand for advanced testing solutions in healthcare settings. These infections, such as urinary tract infections (UTIs), surgical site infections, and bloodstream infections, pose severe risks to patient health and have led to extended hospital stays and higher mortality rates. According to the Centers for Disease Control and Prevention (CDC), HAIs affect millions of patients annually, prompting the development of more precise and rapid diagnostic tools. Governments and healthcare organizations worldwide have launched initiatives to combat HAIs. For instance, the World Health Organization (WHO) promotes stringent hygiene protocols, while countries like the UK have introduced financial penalties for hospitals with high infection rates. The increasing focus on real-time, accurate testing methods, such as Polymerase Chain Reaction (PCR) and rapid diagnostic tests, is expected to drive further advancements in hospital-acquired disease testing.

Hospital-Acquired Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.90% over the forecast period (2024-2032)

Based on Infection type segmentation, Urinary Tract Infections. was predicted to show maximum market share in the year 2023

Based on Testing Technology segmentation, PCR (Polymerase Chain Reaction). was the leading type in 2023

Based on Test Type segmentation, Molecular Diagnostics was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Hospital-Acquired Disease Testing Market- Segmentation Analysis:

The Global Hospital-Acquired Disease Testing Market is segmented on the basis of Infection type, Testing Technology, Test Type, End-User, and Region.

The market is divided into four categories based on Infection type: Urinary Tract Infections, Surgical Site Infections, Respiratory Infections, and Bloodstream Infections. Urinary Tract Infections (UTIs) rank highest due to their prevalence in healthcare settings, followed by Surgical Site Infections, which are critical post-operative concerns. Respiratory Infections come next, with Bloodstream Infections being the least common yet severe.

The market is divided into four categories based on Testing Technology: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Microbial Culture, and Rapid Diagnostics. PCR (Polymerase Chain Reaction) leads due to its accuracy and speed, followed by ELISA (Enzyme-Linked Immunosorbent Assay), which is widely used for antibody detection. Microbial Culture ranks next, with Rapid Diagnostics being the least prioritized.

Hospital-Acquired Disease Testing Market- Geographical Insights

The Hospital-Acquired Disease Testing Market shows significant regional variation, with North America leading due to its advanced healthcare infrastructure and high incidence of hospital-acquired infections (HAIs), which affect approximately 1 in 31 hospitalized patients. Europe follows closely, driven by stringent regulations and increased awareness of infection control measures. In Asia-Pacific, rapid urbanization and the expansion of healthcare facilities contribute to market growth, particularly in countries like India and China, where hospital-acquired infections are becoming a pressing concern. Initiatives such as the World Health Organization's Global Infection Prevention and Control Network aim to enhance surveillance and management of HAIs in low-resource settings, further stimulating demand. Meanwhile, Latin America and the Middle East are witnessing growth as hospitals upgrade their testing capabilities to combat rising infection rates. These regions are increasingly adopting advanced diagnostic technologies, showcasing a global trend towards improving patient safety and quality of care in healthcare settings.

Hospital-Acquired Disease Testing Market- Competitive Landscape:

The Hospital-Acquired Disease Testing Market is characterized by a competitive landscape with key players such as Abbott Laboratories, Roche Diagnostics, and bioMerieux leading in North America, which is the dominant region due to its extensive healthcare systems and significant investment in diagnostic technologies. Europe follows, where companies like Siemens Healthineers and Thermo Fisher Scientific are strengthening their positions through strategic partnerships and innovations in infection detection methods. In the Asia-Pacific region, local players are emerging, driven by the increasing prevalence of hospital-acquired infections, with countries like India and China ramping up their testing capabilities to meet rising demand. Notably, the Indian government has launched initiatives to enhance infection control practices in hospitals, further boosting market growth. Meanwhile, in Latin America and the Middle East, companies are focusing on expanding their distribution networks and increasing awareness about HAIs, contributing to market dynamics. Overall, the competitive landscape is marked by innovation and strategic collaborations aimed at improving patient outcomes across diverse healthcare settings.

Recent Developments:

In November 2021, PINC AI(TM) Applied Sciences and Molnlycke Health Care AB launched a clinical trial to evaluate the effectiveness of Molnlycke's Mepilex Border Flex dressings in reducing hospital-acquired pressure injuries (HAPIs) in acute care settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cepheid Inc. (A Danaher Company)
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • QuidelOrtho Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032

  • Urinary Tract Infections
  • Surgical Site Infections
  • Respiratory Infections
  • Bloodstream Infections

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TESTING TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • PCR (Polymerase Chain Reaction)
  • ELISA (Enzyme-Linked Immunosorbent Assay)
  • Microbial Culture
  • Rapid Diagnostics

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Conventional Culture Tests

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Ambulatory Surgery Centers
  • Academic & Research Institutes

GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hospital-Acquired Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hospital-Acquired Disease Testing Market Snippet by Infection type
    • 2.1.2. Hospital-Acquired Disease Testing Market Snippet by Testing Technology
    • 2.1.3. Hospital-Acquired Disease Testing Market Snippet by Test Type
    • 2.1.4. Hospital-Acquired Disease Testing Market Snippet by End-User
    • 2.1.5. Hospital-Acquired Disease Testing Market Snippet by Country
    • 2.1.6. Hospital-Acquired Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Hospital-Acquired Disease Testing Key Market Trends

  • 3.1. Hospital-Acquired Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hospital-Acquired Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hospital-Acquired Disease Testing Market Opportunities
  • 3.4. Hospital-Acquired Disease Testing Market Future Trends

4. Hospital-Acquired Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hospital-Acquired Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hospital-Acquired Disease Testing Market Landscape

  • 6.1. Hospital-Acquired Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hospital-Acquired Disease Testing Market - By Infection type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Infection type, 2023 & 2032 (%)
    • 7.1.2. Urinary Tract Infections
    • 7.1.3. Surgical Site Infections
    • 7.1.4. Respiratory Infections
    • 7.1.5. Bloodstream Infections

8. Hospital-Acquired Disease Testing Market - By Testing Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Testing Technology, 2023 & 2032 (%)
    • 8.1.2. PCR (Polymerase Chain Reaction)
    • 8.1.3. ELISA (Enzyme-Linked Immunosorbent Assay)
    • 8.1.4. Microbial Culture
    • 8.1.5. Rapid Diagnostics

9. Hospital-Acquired Disease Testing Market - By Test Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 9.1.2. Molecular Diagnostics
    • 9.1.3. Immunoassays
    • 9.1.4. Conventional Culture Tests

10. Hospital-Acquired Disease Testing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Ambulatory Surgery Centers
    • 10.1.5. Academic & Research Institutes

11. Hospital-Acquired Disease Testing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hospital-Acquired Disease Testing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hospital-Acquired Disease Testing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hospital-Acquired Disease Testing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Hospital-Acquired Disease Testing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Hospital-Acquired Disease Testing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hospital-Acquired Disease Testing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. Becton, Dickinson and Company
    • 12.2.3. bioMerieux S.A.
    • 12.2.4. Bio-Rad Laboratories, Inc.
    • 12.2.5. Cardinal Health, Inc.
    • 12.2.6. Cepheid Inc. (A Danaher Company)
    • 12.2.7. Danaher Corporation
    • 12.2.8. F. Hoffmann-La Roche AG
    • 12.2.9. GenMark Diagnostics, Inc.
    • 12.2.10. Hologic, Inc.
    • 12.2.11. Luminex Corporation
    • 12.2.12. Merck KGaA
    • 12.2.13. Qiagen N.V.
    • 12.2.14. QuidelOrtho Corporation
    • 12.2.15. Siemens Healthineers AG
    • 12.2.16. Thermo Fisher Scientific Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us